Update: Added data from study of new patient populations Medtronic (NYSE:MDT) said today it released the 1st real-world registry study of its CoreValve transcatheter aortic valve implant, reporting outcomes in-line with its clinical trials of the device. The medtech giant also released new data from 3 studies focusing on new patient populations with significant comorbidities today. […]
Medtronic
Medtronic sponsors Harvard Business School, NEJM value-based healthcare brain trust
Medtronic (NYSE:MDT) said today it is exclusively sponsoring the Insight Center, a collaborative program between the Harvard Business Journal and the New England Journal of Medicine focusing on value-based healthcare. The Insight Center aims to provide an online forum for leaders in policy, medicine and academia, Medtronic said. This year’s theme for the center is “Measuring […]
TCT 2015: Early data on Medtronic’s drug-filled stent
Early data from a small set of patients implanted with Medtronic‘s (NYSE:MDT) drug-filled stent, presented today at the annual Transcatheter Cardiovascular Therapeutics conference in San Francisco, showed that the device “achieved rapid and well-controlled stent coverage,” the company said today. The DFS is built using the Fridley, Minn.-based medical device giant’s Resolute Integrity and Resolute Onyx stents, using […]
FDA clears Medtronic’s Tyrx envelope for DBS devices
Medtronic (NYSE:MDT) said today that it’s launching its Tyrx surgical envelope in the U.S. for use with deep-brain stimulation devices, after it won 510(k) clearance from the FDA for use of the infection-fighting envelope with implantable neurostimulators. Fridley, Minn.-based Medtronic said it’s planning to make the Tyrx device, acquired for $160 million in January 2014, available for […]
Medtronic issues new software for SuperDimension lung device
Medtronic (NYSE:MDT) said today it launched the next generation version of its SuperDimension lung navigation system software. The SuperDimension navigation system uses a patients CT scan to generate a 3D virtual bronchial tree which allows operating physicians to map pathways to pulmonary targets during electromagnetic bronchoscopy procedures, the Fridley, Minn.-based company said. “This minimally invasive device helps […]
Medtronic participates in $6.8m Mayo Clinic epilepsy project
Medtronic (NYSE:MDT) will be joining the Mayo Clinic in a new $6.8 million National Institutes of Health funded project to develop intelligent devices to track and treat abnormal brain activity in epilepsy patients. The funds come from a 5-year federal grant from the NIH as part of a presidential initiative aimed at better understanding and researching the […]
Diabetes: Medtronic retires Sof-sensor glucose sensor
Medtronic (NYSE:MDT) last week told patients that it plans to sunset its Sof-sensor glucose sensor as of Dec. 1 and move patients to its newer Enlite device. In a Sept. 30 notice, Fridley, Minn.-based Medtronic said it’s discontinuing the Sof-sensor, its oldest continuous glucose monitoring sensor, isn’t related to the sensor’s safety or performance. “Our business is […]
Medtronic closes TMVI developer Twelve Inc. buy
Medtronic (NYSE:MDT) said today it closed its $458 million purchase of transcatheter mitral valve replacement device developer Twelve Inc. Medtronic will pay $408 million for the developer and another $50 million pegged to CE Mark approval in the European Union for the Twelve TMVR device, the company said. “This acquisition supports Medtronic’s therapy innovation strategy, as […]
Medtronic touts 5-year Valiant stent graft data
Medtronic (NYSE:MDT) today touted follow-up data from the Valor II study of its Valiant stent graft, saying patients with descending thoracic aortic aneurysms showed 94.8% freedom from aneurysm-related mortality at 5 years. Fridley, Minn.-based Medtronic, which originally won PMA approval for Valiant in April 2011, said the results show the durability of the Valiant device. The Valor II […]
Medtronic wins expanded FDA PMA for Verify system
Medtronic (NYSE:MDT) said yesterday it won an expanded FDA premarket approval for its Verify system for testing patients for use with its Interstim bladder or bowel control sacral neuromodulation device during basic evaluations. The Verify allows patients with overactive bladder, non-obstructive urinary retention or bowel incontinence to test Interstim system for 3-7 days before making a long-term commitment, the Fridley, […]
Medtronic ponies up $500M to free up $9B in cash
Medtronic (NYSE:MDT) said yesterday it underwent internal restructuring after its $50 billion merger with Covidien that resulted in a 1-time charge of approximately $500 million in income tax to the U.S, according to an SEC filing. As a result, the company has freed up approximately $9.3 billion in assets previously held by U.S.-controlled subsidiaries that exist […]
